Hemlibra and Overdose - a phase IV clinical study of FDA data

Summary:

Overdose is reported as a side effect among people who take Hemlibra (emicizumab), especially for people who are male, 10-19 old, have been taking the drug for 1 - 2 years also take Amlodipine, and have Factor viii inhibition.

The phase IV clinical study analyzes which people have Overdose when taking Hemlibra. It is created by eHealthMe based on reports of 6,078 people who have side effects when taking Hemlibra from the FDA, and is updated regularly.

What is Hemlibra?

Hemlibra has active ingredients of emicizumab. eHealthMe is studying from 6,078 Hemlibra users. Check the latest studies of Hemlibra.

What is Overdose?

Overdose is found to be associated with 2,228 drugs and 2,470 conditions by eHealthMe. Check the latest studies of Overdose.

On Jul, 05, 2026

6,078 people reported to have side effects when taking Hemlibra.
Among them, 11 people (0.18%) have Overdose.

Among these 11 people:

How long have people been on Hemlibra when they have Overdose? *

What is the gender of people who have Overdose when taking Hemlibra? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Overdose when taking Hemlibra? *

What are other drugs people take besides Hemlibra? *

Paracetamol: 1 person, 9.09%
Amlodipine: 1 person, 9.09%

What are other side effects people have besides Overdose? *

Drug Level Increased: 2 people, 18.18%
Activated Partial Thromboplastin Time Shortened: 2 people, 18.18%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 1 person, 9.09%

What are the existing conditions these people have? *

Factor Viii Inhibition (suppression of factor viii): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Hemlibra and have Overdose?

- Check whether Overdose is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hemlibra:

Hemlibra (6,078 reports)

Overdose treatments and more:

Overdose (229,245 reports)

Browse all side effects of Hemlibra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Overdose:

Overdose (2,228 drugs)

Browse all the conditions that are associated with Overdose:

Overdose (2,470 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on emicizumab (the active ingredients of Hemlibra) and Hemlibra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.